Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial.

ABSTRACT:

SUBMITTER: Crowley MJ 

PROVIDER: S-EPMC7440910 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature